MIRO Insider Transactions
Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2023-01-13 | Douglas James Michael | officer: CHIEF FINANCIAL OFFICER | 40,000 | A-Award | A | 40,000 | 3.26 | 130,400.00 |
2023-01-13 | Douglas James Michael | officer: CHIEF FINANCIAL OFFICER | 20,000 | A-Award | A | 20,000 | 0.00 | 0.00 |
2023-01-13 | Barry John Joseph | officer: VICE PRESIDENT OF R&D | 20,000 | A-Award | A | 20,000 | 3.26 | 65,200.00 |
2023-01-13 | Barry John Joseph | officer: VICE PRESIDENT OF R&D | 29,235 | A-Award | A | 10,000 | 0.00 | 0.00 |
2023-01-13 | Ross Jeffrey James | director, officer: CHIEF EXECUTIVE OFFICER | 100,000 | A-Award | A | 100,000 | 3.26 | 326,000.00 |
2023-01-13 | Ross Jeffrey James | director, officer: CHIEF EXECUTIVE OFFICER | 365,026 | F-InKind | D | 4,487 | 3.26 | 14,627.62 |
2023-01-13 | Ross Jeffrey James | director, officer: CHIEF EXECUTIVE OFFICER | 369,513 | A-Award | A | 50,000 | 0.00 | 0.00 |
2022-12-06 | Ross Jeffrey James | director, officer: CHIEF EXECUTIVE OFFICER | 0 | M-Exempt | D | 37,500 | 1.25 | 46,875.00 |
2022-12-06 | Ross Jeffrey James | director, officer: CHIEF EXECUTIVE OFFICER | 319,513 | F-InKind | D | 11,575 | 4.05 | 46,878.75 |
2022-12-06 | Ross Jeffrey James | director, officer: CHIEF EXECUTIVE OFFICER | 331,088 | M-Exempt | A | 37,500 | 1.25 | 46,875.00 |
2022-10-01 | Barry John Joseph | officer: VICE PRESIDENT OF R&D | 19,235 | F-InKind | D | 765 | 4.38 | 3,350.70 |
2022-08-10 | Maag Peter | director | 35,009 | A-Award | A | 12,788 | 0.00 | 0.00 |
2022-08-10 | BUCKMAN PAUL | director | 21,343 | A-Award | A | 12,788 | 0.00 | 0.00 |
2022-08-10 | ERB JOHN L | director | 25,010 | A-Award | A | 12,788 | 0.00 | 0.00 |
2022-08-10 | Burke William P. Mr. | director | 48,905 | A-Award | A | 12,788 | 0.00 | 0.00 |
2022-08-10 | Heine Lisa Wipperman | director | 48,905 | A-Award | A | 12,788 | 0.00 | 0.00 |
2022-03-15 | Ross Jeffrey James | director, officer: CHIEF EXECUTIVE OFFICER | 0 | M-Exempt | D | 35,438 | 1.25 | 44,297.50 |
2022-03-15 | Ross Jeffrey James | director, officer: CHIEF EXECUTIVE OFFICER | 293,588 | M-Exempt | A | 35,438 | 1.25 | 44,297.50 |
2022-03-01 | Douglas James Michael | officer: Chief Financial Officer | 180,000 | A-Award | A | 180,000 | 3.73 | 671,400.00 |
2022-01-13 | Barry John Joseph | officer: VICE PRESIDENT OF R&D | 20,000 | A-Award | A | 20,000 | 4.20 | 84,000.00 |
2022-01-13 | Barry John Joseph | officer: VICE PRESIDENT OF R&D | 20,000 | A-Award | A | 20,000 | 4.20 | 84,000.00 |
2022-01-13 | NIEBUR BRIAN | officer: CHIEF FINANCIAL OFFICER | 20,000 | A-Award | A | 20,000 | 4.20 | 84,000.00 |
2022-01-13 | NIEBUR BRIAN | officer: CHIEF FINANCIAL OFFICER | 24,668 | A-Award | A | 10,000 | 0.00 | 0.00 |
2022-01-13 | Ross Jeffrey James | director, officer: CHIEF EXECUTIVE OFFICER | 100,000 | A-Award | A | 100,000 | 4.20 | 420,000.00 |
2022-01-13 | Ross Jeffrey James | director, officer: CHIEF EXECUTIVE OFFICER | 258,150 | A-Award | A | 50,000 | 0.00 | 0.00 |
2022-01-13 | Kattungal Laji | officer: VICE PRESIDENT OF QUALITY | 20,000 | A-Award | A | 20,000 | 4.20 | 84,000.00 |
2022-01-13 | Kattungal Laji | officer: VICE PRESIDENT OF QUALITY | 10,000 | A-Award | A | 10,000 | 0.00 | 0.00 |
2022-01-03 | Ross Jeffrey James | director, officer: Chief Executive Officer | 1,500 | A-Award | A | 1,500 | 4.73 | 7,095.00 |
2022-01-03 | Burke William P. Mr. | director | 36,117 | A-Award | A | 31,712 | 0.00 | 0.00 |
2022-01-03 | Burke William P. Mr. | director | 4,405 | A-Award | A | 4,405 | 0.00 | 0.00 |
2022-01-03 | Heine Lisa Wipperman | director | 36,117 | A-Award | A | 31,712 | 0.00 | 0.00 |
2022-01-03 | Heine Lisa Wipperman | director | 4,405 | A-Award | A | 4,405 | 0.00 | 0.00 |
2022-01-03 | Barry John Joseph | officer: Vice President of R&D | 1,500 | A-Award | A | 1,500 | 4.73 | 7,095.00 |
2022-01-03 | NIEBUR BRIAN | officer: Chief Financial Officer | 1,500 | A-Award | A | 1,500 | 4.73 | 7,095.00 |
2022-01-03 | Kattungal Laji | officer: Vice President of Quality | 1,500 | A-Award | A | 1,500 | 4.73 | 7,095.00 |
2021-10-01 | NIEBUR BRIAN | officer: Chief Financial Officer | 50,000 | A-Award | A | 50,000 | 6.97 | 348,500.00 |
2021-10-01 | NIEBUR BRIAN | officer: Chief Financial Officer | 14,668 | A-Award | A | 8,000 | 0.00 | 0.00 |
2021-10-01 | Barry John Joseph | officer: Vice President of R&D | 70,000 | A-Award | A | 70,000 | 6.97 | 487,900.00 |
2021-10-01 | Barry John Joseph | officer: Vice President of R&D | 10,000 | A-Award | A | 10,000 | 0.00 | 0.00 |
2021-06-28 | Ross Jeffrey James | director, officer: CHIEF EXECUTIVE OFFICER | 0 | C-Conversion | D | 4,400 | 0.00 | 0.00 |
2021-06-28 | Ross Jeffrey James | director, officer: CHIEF EXECUTIVE OFFICER | 208,150 | C-Conversion | A | 4,400 | 0.00 | 0.00 |
2021-06-28 | Cheshire MD Holdings, LLC | 10 percent owner | 0 | C-Conversion | D | 1,004,887 | 0.00 | 0.00 |
2021-06-28 | Cheshire MD Holdings, LLC | 10 percent owner | 0 | C-Conversion | D | 1,004,887 | 0.00 | 0.00 |
2021-06-28 | Cheshire MD Holdings, LLC | 10 percent owner | 1,980,091 | C-Conversion | A | 1,046,757 | 0.00 | 0.00 |
2021-06-28 | Cheshire MD Holdings, LLC | 10 percent owner | 933,334 | C-Conversion | A | 933,334 | 0.00 | 0.00 |
2021-06-28 | Ross Jeffrey James | officer: Chief Executive Officer | 4,400 | C-Conversion | A | 4,400 | 0.00 | 0.00 |
2021-06-28 | WAGNER MARK T | director | 0 | C-Conversion | D | 3,334 | 0.00 | 0.00 |
2021-06-28 | WAGNER MARK T | director | 3,334 | C-Conversion | A | 3,334 | 0.00 | 0.00 |
2021-06-28 | BUCKMAN PAUL | director | 0 | C-Conversion | D | 3,000 | 0.00 | 0.00 |
2021-06-28 | BUCKMAN PAUL | director | 8,555 | C-Conversion | A | 3,000 | 0.00 | 0.00 |
2021-06-28 | EIBENSTEINER RONALD E | director | 0 | C-Conversion | D | 120,000 | 0.00 | 0.00 |
2021-06-28 | EIBENSTEINER RONALD E | director | 0 | C-Conversion | D | 120,000 | 0.00 | 0.00 |
2021-06-28 | EIBENSTEINER RONALD E | director | 0 | C-Conversion | D | 120,000 | 0.00 | 0.00 |
2021-06-28 | EIBENSTEINER RONALD E | director | 20,000 | C-Conversion | A | 20,000 | 0.00 | 0.00 |
2021-06-28 | EIBENSTEINER RONALD E | director | 179,769 | C-Conversion | A | 120,000 | 0.00 | 0.00 |
2021-06-28 | EIBENSTEINER RONALD E | director | 59,769 | C-Conversion | A | 59,769 | 0.00 | 0.00 |
2021-06-28 | ERB JOHN L | director | 0 | C-Conversion | D | 6,667 | 0.00 | 0.00 |
2021-06-28 | ERB JOHN L | director | 12,222 | C-Conversion | A | 6,667 | 0.00 | 0.00 |
2021-06-28 | NIEBUR BRIAN | officer: Chief Financial Officer | 0 | C-Conversion | D | 3,334 | 0.00 | 0.00 |
2021-06-28 | NIEBUR BRIAN | officer: Chief Financial Officer | 0 | C-Conversion | D | 3,334 | 0.00 | 0.00 |
2021-06-28 | NIEBUR BRIAN | officer: Chief Financial Officer | 6,668 | C-Conversion | A | 3,334 | 0.00 | 0.00 |
2021-06-28 | NIEBUR BRIAN | officer: Chief Financial Officer | 3,334 | C-Conversion | A | 3,334 | 0.00 | 0.00 |
2021-06-24 | BAXTER INTERNATIONAL INC | 10 percent owner | 0 | C-Conversion | D | 2,083,333 | 0.00 | 0.00 |
2021-06-24 | BAXTER INTERNATIONAL INC | 10 percent owner | 2,083,333 | C-Conversion | A | 2,083,333 | 0.00 | 0.00 |
2021-06-23 | Cheshire MD Holdings, LLC | 10 percent owner | 0 | X-InTheMoney | A | 240,000 | 7.50 | 1,800,000.00 |
2021-06-23 | Cheshire MD Holdings, LLC | 10 percent owner | 1,004,887 | X-InTheMoney | A | 956,887 | 0.00 | 0.00 |
2021-06-23 | Cheshire MD Holdings, LLC | 10 percent owner | 48,000 | S-Sale | A | 192,000 | 0.00 | 0.00 |
2021-06-23 | Cheshire MD Holdings, LLC | 10 percent owner | 240,000 | X-InTheMoney | A | 240,000 | 0.00 | 0.00 |
2021-06-23 | Maag Peter | director | 22,221 | A-Award | A | 16,666 | 0.00 | 0.00 |
2021-06-23 | Maag Peter | director | 5,555 | A-Award | A | 5,555 | 0.00 | 0.00 |
2021-06-23 | ERB JOHN L | director | 5,555 | A-Award | A | 5,555 | 0.00 | 0.00 |
2021-06-23 | BUCKMAN PAUL | director | 5,555 | A-Award | A | 5,555 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.